Lv1
40 积分 2023-11-13 加入
Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphoma
2天前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
27天前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
27天前
已完结
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
2个月前
已完结
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma
3个月前
已完结
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma
3个月前
已完结
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study
3个月前
已完结
Preoperative tumor abnormal protein is a promising biomarker for predicting hepatocellular carcinoma oncological outcome following curative resection
3个月前
已完结
Clinical application of serum tumor abnormal protein combined with tumor markers in lung cancer patients
3个月前
已完结
皖公网安备34019202002308
